Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
40.65%
operating margin TTM
47.74%
revenue TTM
2.21 Billion
revenue per share TTM
49.52$
valuation ratios | |
|---|---|
| pe ratio | 17.81 |
| peg ratio | 6.17 |
| price to book ratio | 3.44 |
| price to sales ratio | 7.38 |
| enterprise value multiple | 14.32 |
| price fair value | 3.44 |
profitability ratios | |
|---|---|
| gross profit margin | 88.59% |
| operating profit margin | 47.74% |
| pretax profit margin | 53.27% |
| net profit margin | 40.65% |
| return on assets | 17.3% |
| return on equity | 18.83% |
| return on capital employed | 21.95% |
liquidity ratios | |
|---|---|
| current ratio | 6.40 |
| quick ratio | 6.07 |
| cash ratio | 2.45 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 180.51 |
| operating cycle | 215.24 |
| days of payables outstanding | 478.62 |
| cash conversion cycle | -263.38 |
| receivables turnover | 10.51 |
| payables turnover | 0.76 |
| inventory turnover | 2.02 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 61.46 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | 25.61 |
| cash per share | 67.83 |
| operating cash flow per share | 35.53 |
| free cash flow operating cash flow ratio | 0.72 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 3.58 |
Frequently Asked Questions
When was the last time United Therapeutics Corporation (NASDAQ:UTHR) reported earnings?
United Therapeutics Corporation (UTHR) published its most recent earnings results on 29-10-2025.
What is United Therapeutics Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. United Therapeutics Corporation (NASDAQ:UTHR)'s trailing twelve months ROE is 18.83%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. United Therapeutics Corporation (UTHR) currently has a ROA of 17.3%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did UTHR's net profit margin stand at?
UTHR reported a profit margin of 40.65% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is UTHR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.40 in the most recent quarter. The quick ratio stood at 6.07, with a Debt/Eq ratio of 0.00.